US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 18.830
  • +0.400+2.17%
Close Dec 13 16:00 ET
  • 18.640
  • -0.190-1.01%
Post 19:59 ET
762.75MMarket Cap-3.61P/E (TTM)

Keros Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Keros Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.900M--
--2024/Q4-- / 46.962M--
--2024/Q3388.000K / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q183.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.900M--
--2024/Q4-- / 46.962M--
--2024/Q3388.000K / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q183.000K / 0.000--

Unlock Free Earnings Estimates

Keros Therapeutics Earnings Reports

  • Keros Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:30 ET

  • Keros Therapeutics | 8-K: Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results

    Nov 6 16:10 ET

  • Keros Therapeutics | 8-K: Keros Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 7 16:09 ET

  • Keros Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 16:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 13, 2024

    Strong Buy

    • Buy

      81.25%

    • Hold

      18.75%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data